M6223
Showing 1 - 18 of 18
Metastatic Solid Tumors Trial in Canada, United States (M6223, Bintrafusp alfa)
Recruiting
- Metastatic Solid Tumors
- M6223
- Bintrafusp alfa
-
Nashville, Tennessee
- +3 more
Oct 14, 2021
Locally Advanced or Metastatic Urothelial Carcinoma Trial in United States (Avelumab, Sacituzumab Govitecan, M6223)
Recruiting
- Locally Advanced or Metastatic Urothelial Carcinoma
- Avelumab
- +3 more
-
Coeur d'Alene, Idaho
- +19 more
Oct 4, 2022
Moderate-to-Severe Atopic Dermatitis Trial in Worldwide (Placebo, Nemolizumab)
Active, not recruiting
- Moderate-to-Severe Atopic Dermatitis
- Placebo
- Nemolizumab
-
Little Rock, Arkansas
- +201 more
Aug 24, 2022
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
Recruiting
- Type 2 Diabetes Mellitus
- Cardiovascular Diseases
- SU
- +13 more
-
Oakland, California
- +5 more
Oct 18, 2022
Alcohol Abuse Trial in Storrs (Yoga, Distress Tolerance)
Recruiting
- Alcohol Abuse
- Yoga
- Distress Tolerance
-
Storrs, ConnecticutUniversity of Connecticut
Jul 14, 2021
Active Psoriatic Arthritis Trial in Worldwide (TILD, matching injections)
Recruiting
- Active Psoriatic Arthritis
- TILD
- matching placebo injections
-
Anniston, Alabama
- +98 more
Nov 25, 2022
The Effect of Smoking on Peri-implantitis
Not yet recruiting
- Periimplantitis
- +2 more
- Recruiting samples
- (no location specified)
Nov 20, 2023
RSV Infection Trial in Worldwide (MK-1654, Palivizumab, Placebo)
Recruiting
- RSV Infection
- Clesrovimab
- +2 more
-
Long Beach, California
- +129 more
Jan 25, 2023
Psychosis, Schizoaffective Disorder, Schizophrenia Trial in New York (OnTrack>TheGame (OTG), Recovery Videos (RV))
Completed
- Psychosis
- +2 more
- OnTrack>TheGame (OTG)
- Recovery Videos (RV)
-
New York, New YorkNew York State Psychiatric Institute
Nov 24, 2021
NSCLC Trial in Worldwide (FKB238 (bevacizumab), Avastin (bevacizumab), Paclitaxel)
Completed
- Carcinoma, Non-Small-Cell Lung
- FKB238 (bevacizumab)
- +3 more
-
Fountain Valley, California
- +146 more
Feb 25, 2022
Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)
Active, not recruiting
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- Azacitidine
- Durvalumab
-
New Haven, Connecticut
- +94 more
Jun 9, 2022
Duchenne Muscular Dystrophy Trial in Worldwide (Placebo, SRP-4053)
Cystitis, Interstitial Trial in Worldwide (Tanezumab, Placebo)
Terminated
- Cystitis, Interstitial
- Tanezumab
- Placebo
-
Mobile, Alabama
- +170 more
Jul 12, 2021
Breast Cancer Metastatic Trial in Worldwide (PF-03084014, Docetaxel)
Terminated
- Breast Cancer Metastatic
-
Birmingham, Alabama
- +15 more
Mar 14, 2019
HIV Infection Trial in Thailand (ALVAC-HIV vCP1521 + AIDSVAX, ALVAC Placebo + AIDSVAX Placebo)
Completed
- HIV Infection
- ALVAC-HIV vCP1521 + AIDSVAX
- ALVAC Placebo + AIDSVAX Placebo
-
Ban Lamung District, Chon Buri, Thailand
- +7 more
Apr 10, 2019
Diabetes, Type 2 Trial in Worldwide (Avandamet 6 mg/1500 mg (ttd), Avandamet 4 mg/1000 mg (ttd), Avandamet 2 mg/500 mg (ttd))
Completed
- Diabetes Mellitus, Type 2
- Avandamet 6 mg/1500 mg (ttd)
- +7 more
-
Tuscaloosa, Alabama
- +115 more
Oct 11, 2016
Testing of Antigenic Sites of AIDS Virus, HTLV-III Recognized by
Completed
- HIV Infections
- Healthy
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008